Deep search
Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent

News

Sony Buys Stake In Bandai Namco

Deadline on MSN · 2d
Sony Pays $464M For Stake In ‘Pac-Man' Owner Bandai Namco
Sony Corp. has taken a small stake in Tekken and Pac-Man games giant Bandai Namco, as part of a strategic business alliance. Japan-based Sony paid 68 billion yen ($464M) for a 2.5% stake in its compatriot company,
Variety on MSN · 2d
Sony Takes Strategic Stake in Bandai Namco With $464 Million Deal
Sony acquires 2.5% stake in Bandai Namco for $464 million as entertainment giants partner to expand anime and manga IP globally in booming market.
TechStory · 3h
Sony Acquires 2.5% Stake in Bandai Namco
Sony has acquired a stake in Bandai Namco, forming a partnership aimed at expanding fan engagement around anime, manga, gaming, and beyond
1d
Sony and Bandai Namco Form 68 Billion Yen Strategic Alliance to “Unlock Potential of Compelling IP”
Sony and Bandai Namco have formed a strategic partnership to collaborate on new IP releases for games, music, and Anime.
Gamepressure
1d
Sony is closing in on Elden Ring's devs. Nightreign and Shadow of the Erdtree DLC are big wins for FromSoftware
Shadow of the Erdtree and Elden Ring: Nightreign. Sony, meanwhile, announced a major investment in its partnership with ...
2don MSN
After increasing shares in FromSoftware owner Kadokawa, Sony now owns 2.5% of Elden Ring publisher Bandai Namco
Sony has snapped up 2.5 percent of publisher Bandai Namco as part of a "strategic partnership" that's primarily focused on ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy